1. Home
  2. TMDX vs NABL Comparison

TMDX vs NABL Comparison

Compare TMDX & NABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • NABL
  • Stock Information
  • Founded
  • TMDX 1998
  • NABL 2000
  • Country
  • TMDX United States
  • NABL United States
  • Employees
  • TMDX N/A
  • NABL N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NABL Computer Software: Prepackaged Software
  • Sector
  • TMDX Health Care
  • NABL Technology
  • Exchange
  • TMDX Nasdaq
  • NABL Nasdaq
  • Market Cap
  • TMDX 2.3B
  • NABL 1.9B
  • IPO Year
  • TMDX 2019
  • NABL N/A
  • Fundamental
  • Price
  • TMDX $88.24
  • NABL $6.35
  • Analyst Decision
  • TMDX Buy
  • NABL Buy
  • Analyst Count
  • TMDX 10
  • NABL 4
  • Target Price
  • TMDX $118.44
  • NABL $9.38
  • AVG Volume (30 Days)
  • TMDX 1.1M
  • NABL 1.3M
  • Earning Date
  • TMDX 04-29-2025
  • NABL 05-08-2025
  • Dividend Yield
  • TMDX N/A
  • NABL N/A
  • EPS Growth
  • TMDX N/A
  • NABL 24.64
  • EPS
  • TMDX 1.01
  • NABL 0.16
  • Revenue
  • TMDX $441,540,000.00
  • NABL $466,147,000.00
  • Revenue This Year
  • TMDX $25.33
  • NABL $7.38
  • Revenue Next Year
  • TMDX $20.53
  • NABL $9.67
  • P/E Ratio
  • TMDX $87.37
  • NABL $39.69
  • Revenue Growth
  • TMDX 82.74
  • NABL 10.49
  • 52 Week Low
  • TMDX $55.00
  • NABL $6.21
  • 52 Week High
  • TMDX $177.37
  • NABL $15.49
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 70.61
  • NABL 34.64
  • Support Level
  • TMDX $82.62
  • NABL $6.48
  • Resistance Level
  • TMDX $88.48
  • NABL $6.81
  • Average True Range (ATR)
  • TMDX 5.48
  • NABL 0.35
  • MACD
  • TMDX 1.98
  • NABL 0.01
  • Stochastic Oscillator
  • TMDX 99.09
  • NABL 10.70

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. it also has a presence in the United Kingdom and all other International regions.

Share on Social Networks: